| ￥1200 | |
| A03869 | |
|
|
|
|
|
|
|
|
|
| Specificity | This product is specific to alpha Actinin 4 |
| Host Species | Rabbit |
| Immunogen | A synthesized peptide derived from human alpha Actinin 4 |
| Species Reactivity | Human; Mouse; Rat |
| Conjugate | Unconjugated |
| Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product. | |||||||||||||||
|
|||||||||||||||
| Form | Liquid |
| Storage Buffer | Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol. |
| Storage Instructions | Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed. |
| Purification | Affinity-chromatography |
| Isotype | Rabbit IgG |
| Clonality | Monoclonal |
| Target Background | F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein (Probable). Probably involved in vesicular trafficking via its association with the CART complex. The CART complex is necessary for efficient transferrin receptor recycling but not for EGFR degradation |
| Synonyms | actinin 4; Actinin alpha 4; actinin4; ACTN 4; Alpha-actinin-4; F actin cross linking protein; Focal segmental glomerulosclerosis 1; FSGS1; Non muscle alpha actinin 4; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
